CTOs on the Move


 
Valiant Living is a company that offers comprehensive outpatient treatment and recovery services for men and their families, as well as enhanced recovery living environments for men who need a productive transition period after primary treatment.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

PDI, Inc.

PDI Inc. is a provider of contract sales teams to pharmaceutical companies, offering a range of sales support services.

CliniQAl Consult Corporation

CliniQAl Consult Corporation is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Volition

Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring. Volition`s research and development activities are centered in Belgium, with an innovation laboratory in California and additional offices in Texas, London, and Singapore, as the company focuses on bringing its diagnostic and disease monitoring products to market.

Hughes BioPharma Advisers

Hughes BioPharma Advisers is a Darien, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medgenics

Medgenics is a clinical-stage biopharmaceutical company developing an innovative and proprietary platform technology - a biological "Biopump" - which allows patients to produce, within their bodies and on a long-term basis, their own natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C.